Title: Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
Authors: Decramer, Marc ×
Anzueto, Antonio
Kerwin, Edward
Kaelin, Thomas
Richard, Nathalie
Crater, Glenn
Tabberer, Maggie
Harris, Stephanie
Church, Alison #
Issue Date: Jun-2014
Publisher: Elsevier
Series Title: The Lancet Respiratory Medicine vol:2 issue:6 pages:472-86
Article number: 10.1016/S2213-2600(14)70065-7
Abstract: Combination long-acting bronchodilator treatment might be more effective than long-acting bronchodilator monotherapy for the treatment of chronic obstructive pulmonary disease (COPD). We aimed to compare the efficacy and safety of umeclidinium (UMEC) plus vilanterol (VI) with tiotropium (TIO) monotherapy, UMEC monotherapy, or VI monotherapy in patients with moderate to very severe COPD.
ISSN: 2213-2600
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Pneumology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science